---
title: "Machine learning on rectal biopsy transcriptomics predicts relapse after anti-TNF withdrawal in ul"
id: "medrxiv-0-machine-learning-predicts-relapse-after-anti-tnf-withdrawal-in-ulcerative"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-0-machine-learning-predicts-relapse-after-anti-tnf-withdrawal-in-ulcerative"
content_type: "clinical_feed_article"
specialty: "Gastroenterology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1?rss=1"
published_at: "2026-10-07T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Machine learning on rectal biopsy transcriptomics predicts relapse after anti-TNF withdrawal in ul
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-0-machine-learning-predicts-relapse-after-anti-tnf-withdrawal-in-ulcerative
- **Specialty:** [Gastroenterology](https://medichelpline.com/clinical-feed/gastroenterology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1?rss=1)
- **Published At:** 2026-10-07T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study used rectal biopsy RNA-seq from UC patients in the randomized BIOSTOP trial (n=136) to develop a model predicting relapse after **anti-TNF** withdrawal. - Patients were randomized to an immediate withdrawal group or a maintenance group (stopped after 2 years); baseline biopsies were used for model training and validation. - A semi-supervised machine learning framework combined a shared **UMAP** manifold representation with LabelSpreading applied to a targeted **38-gene** panel. - On the test cohort (maintenance-group baseline samples) the model achieved AUC 0.794, sensitivity 90.3%, specificity 73.1%. - On the inference cohort (maintenance-group 2-year follow-up samples) performance was AUC 0.711, sensitivity 82.9%, specificity 42.3%. - SHAP analysis identified **IL1B**, **TYROBP**, **REG1B**, **S100A8**, and **TNF** as top contributors to predicted relapse risk; **MUC2**, **HMGCS2**, and **CDKN1A** were most predictive of sustained remission. - Authors highlight the model’s high sensitivity as suitable for screening to avoid withdrawal-related relapse but note moderate specificity and call for multi-center validation in larger, more diverse cohorts before clinical use. - Sequencing data will be available on reasonable request to the corresponding author, subject to ethical and data-protection constraints. - Trial ethical approval was provided by the Regional Committee for Medical Research Ethics (REK Midt 2016/531) and the work was funded by the South-Eastern Norway Health Authority (2023090).
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=P3bxy0Ut1j0Uo2xN7o6CYFoK0Q9qPxEMiSGDJ.L_gH0-1791448072.4572306-1.2.1.1-igpA4r.EkkfakSJp64WvmzL_rah1xUtJU43XXFdWyngIgrTa.nLcpPOm28mvAcNx) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Machine learning predicts relapse after anti-TNF withdrawal in ulcerative colitis using rectal biopsy transcriptomics Ghita Bouhddi, Emma Rapp, Piotr Artiemjew, Ingrid Prytz Berset, Frode Lerang, Dag Arne Lihaug Hoff, Espen Sonderaal Bakkevold, Knut E.A. Lundin, Frode Lars Jahnsen, Diana Domanska doi: https://doi.org/10.64898/2026.10.05.26364793 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Ghita Bouhddi 1 Department of Pathology, Oslo University hospital, Oslo, Norway; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ghita%2BBouhddi%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Bouhddi%20G&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AGhita%2BBouhddi%2B) Emma Rapp 2 Department of Pathology, Oslo University hospital, Oslo, Norway,; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Emma%2BRapp%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Rapp%20E&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEmma%2BRapp%2B) Piotr Artiemjew 3 3Faculty of Mathematics and Computer Science, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Piotr%2BArtiemjew%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Artiemjew%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APiotr%2BArtiemjew%2B) Ingrid Prytz Berset 4 Department of Gastroenterology, More & Romsdal Hospital Trust, Alesund, Norway; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ingrid%2BPrytz%2BBerset%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Berset%20IP&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AIngrid%2BPrytz%2BBerset%2B) Frode Lerang 5 Department of Gastroenterology, Ostfold Hospital Trust, Sarpsborg, Norway; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Frode%2BLerang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lerang%20F&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AFrode%2BLerang%2B) Dag Arne Lihaug Hoff 4 Department of Gastroenterology, More & Romsdal Hospital Trust, Alesund, Norway; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Dag%2BArne%2BLihaug%2BHoff%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Hoff%20DA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADag%2BArne%2BLihaug%2BHoff%2B) Espen Sonderaal Bakkevold 1 Department of Pathology, Oslo University hospital, Oslo, Norway; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Espen%2BSonderaal%2BBakkevold%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Bakkevold%20ES&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AEspen%2BSonderaal%2BBakkevold%2B) Knut E.A. Lundin 6 Institute of Clinical Medicine, University of Oslo, Oslo, Norway; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Knut%2BE.A.%2BLundin%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Lundin%20KE&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AKnut%2BE.A.%2BLundin%2B) Frode Lars Jahnsen 1 Department of Pathology, Oslo University hospital, Oslo, Norway; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Frode%2BLars%2BJahnsen%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Jahnsen%20FL&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AFrode%2BLars%2BJahnsen%2B) Diana Domanska 7 Oslo University Hospital * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Diana%2BDomanska%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Domanska%20D&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADiana%2BDomanska%2B) * For correspondence: diana.domanska@gmail.com * [Abstract](https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1316034/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1316034/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1316034/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1316034/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1316034/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1316034/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background There are currently no available biomarkers that predict the clinical outcome of ulcerative colitis (UC) patients after anti-TNF withdrawal. Here we developed a semi-supervised machine learning framework on RNA-seq data derived from rectal biopsies to predict relapse following anti-TNF discontinuation. Methods We included UC patients (n=136) enrolled in the prospective, randomized controlled BIOSTOP trial. Patients were assigned to a withdrawal group (stopped treatment immediately) or a maintenance group (stopped treatment after 2 years). A machine learning framework was trained on gene expression data from mucosal biopsies collected at baseline from the withdrawal group and validated in the maintenance group using baseline samples (test cohort) and 2-year follow-up samples (interference cohort). Results A semi-supervised machine learning model, combining a shared UMAP manifold representation with LabelSpreading on a targeted 38-gene panel achieved an AUC of 0.794, a sensitivity of 90.3%, and a specificity of 73.1% on the test cohort, and an AUC of 0.711, a sensitivity of 82.9%, and a specificity of 42.3% on the inference cohort. Applying Shapley Additive exPlanations (SHAP) we found that IL1B, TYROBP, REG1B, S100A8, and TNF showed the highest predictive importance for relapse risk, whereas MUC2, HMGCS2, and CDKN1A displayed the highest predictive importance for sustained remission. Conclusion The high sensitivity makes the model a promising screening tool to prevent withdrawal-related relapse, though its moderate specificity underscores the need for multi-center validation in larger, more diverse cohorts before clinical deployment. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Regional Committee for Medical Research Ethics (REK Midt 2016/531) I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The sequencing data underlying the results of this analysis will be made available upon reasonable request to the corresponding author, subject to applicable ethical and data-protection requirements. ## Funder Information Declared South-Eastern Norway Health Authority, 2023090 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a [CC-BY-NC 4.0 International license](http://creativecommons.org/licenses/by-nc/4.0/). bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.10.05.26364799v1 "Considerations for implementing a machine learning model for suicide risk in the health systems that serve American Indian communities")[Next ](https://www.medrxiv.org/content/10.64898/2026.10.05.26364769v1 "Targeted Deployment of Long-Acting HIV Pre-Exposure Prophylaxis in sub-Saharan Africa: Modelled Impact on Infections and Programme Costs to 2050") Posted October 07, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/10/07/2026.10.05.26364793.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.10.05.26364793v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/10/07/2026.10.05.26364793.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Machine learning predicts relapse after anti-TNF withdrawal in ulcerative colitis using rectal biopsy transcriptomics Ghita Bouhddi, Emma Rapp, Piotr Artiemjew, Ingrid Prytz Berset, Frode Lerang, Dag Arne Lihaug Hoff, Espen Sonderaal Bakkevold, Knut E.A. Lundin, Frode Lars Jahnsen, Diana Domanska medRxiv 2026.10.05.26364793; doi: https://doi.org/10.64898/2026.10.05.26364793 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.05.26364793v1%26text%3DMachine%2520learning%2520predicts%2520relapse%2520after%2520anti-TNF%2520withdrawal%2520in%2520ulcerative%2520colitis%2520using%2520rectal%2520biopsy%2520transcriptomics "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.05.26364793v1%26t%3DMachine%2520learning%2520predicts%2520relapse%2520after%2520anti-TNF%2520withdrawal%2520in%2520ulcerative%2520colitis%2520using%2520rectal%2520biopsy%2520transcriptomics "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.05.26364793v1%26title%3DMachine%2520learning%2520predicts%2520relapse%2520after%2520anti-TNF%2520withdrawal%2520in%2520ulcerative%2520colitis%2520using%2520rectal%2520biopsy%2520transcriptomics%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.05.26364793v1%26title%3DMachine%2520learning%2520predicts%2520relapse%2520after%2520anti-TNF%2520withdrawal%2520in%2520ulcerative%2520colitis%2520using%2520rectal%2520biopsy%2520transcriptomics "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.10.05.26364793) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.10.05.26364793v1&count=horizontal&via=&text=Machine%20learning%20predicts%20relapse%20after%20anti-TNF%20withdrawal%20in%20ulcerative%20colitis%20using%20rectal%20biopsy%20transcriptomics&counturl=www.medrxiv.org/content/10.64898/2026.10.05.26364793v1 "Tweet This") ## Subject Area * [Gastroenterology ](https://www.medrxiv.org/collection/gastroenterology) Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (626) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (914) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (341) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4891) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (486) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (421) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (661) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1648) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16081) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (34) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1220) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7135) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (738) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1077) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5142) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1448) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1797) * [Hematology](https://www.medrxiv.org/collection/hematology) (592) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1356) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16367) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1185) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (679) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (729) * [Neurology](https://www.medrxiv.org/collection/neurology) (7408) * [Nursing](https://www.medrxiv.org/collection/nursing) (371) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1103) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1266) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1012) * [Oncology](https://www.medrxiv.org/collection/oncology) (3667) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1071) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (399) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (460) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (484) * [Palliative Medicine](https://www.medrxiv.or
## Related Clinical Research

- [Impact of Gut Inflammation on Dietary Sensitivities in IBD Patients](https://medichelpline.com/clinical-feed/medical-news-today-0-losing-good-bacteria-during-inflammation-may-trigger-new-food-sensitivities-in.md)
- [Global stakeholder priorities for point-of-care HIV NAATs: sensitivity, speed, and fingerstick sam](https://medichelpline.com/clinical-feed/plos-one-11-global-stakeholder-preferences-for-point-of-care-hiv-nucleic-acid-amplification.md)
- [Violence and HIV outcomes in female sex workers: global systematic review and meta-analysis](https://medichelpline.com/clinical-feed/plos-medicine-3-impact-of-violence-on-hiv-outcomes-among-female-sex-workers-a-global-systematic.md)
- [Monitoring doxy-PEP impact: when to reassess guidance on STI prophylaxis](https://medichelpline.com/clinical-feed/plos-medicine-0-how-do-we-monitor-doxy-pep-impact-and-when-should-we-consider-revisiting.md)
- [Why U.S. opioid overdose deaths fell sharply — and what we still don’t know](https://medichelpline.com/clinical-feed/stat-news-2-opinion-overdose-deaths-have-plunged-we-need-to-know-why.md)

## Navigation
- [← Back to Gastroenterology Feed](https://medichelpline.com/clinical-feed/gastroenterology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.